Cannabis users’ type 2 diabetes risk quadruples: large study

10/20/2025

Reading time: about 3 minutes

Type 2 Diabetes Risk Quadruples for Cannabis Users, Large Study Finds

A massive review of medical records suggests a surprising link: adults who use cannabis appear far more likely to develop type 2 diabetes than their non-using peers. The finding has reignited debate about long-term health effects as cannabis use climbs worldwide.

Large-scale analysis connects cannabis use with higher diabetes risk

Researchers at Boston Medical Center tapped the TriNetX network to analyze electronic health records from 54 hospitals and clinics across the U.S. and Europe. They examined data gathered between 2010 and 2018 for adults aged 18 to 50.

The team identified nearly 97,000 people with cannabis-related diagnostic codes. These ranged from occasional use to dependence, and included intoxication and withdrawal records. Those patients were matched to more than 4 million individuals with no substance-use diagnoses or major chronic illnesses.

The cohort was tracked for five years to see who developed type 2 diabetes. Researchers adjusted for age, sex, heart disease, cholesterol, blood pressure, and use of alcohol or stimulants.

Magnitude of the association: what the numbers show

Over the follow-up period, the incidence of type 2 diabetes differed markedly between groups.

  • 2.2% of people with cannabis-related diagnoses developed type 2 diabetes.
  • 0.6% of matched non-users developed the disease.

That pattern translates into roughly a fourfold increase in diabetes risk among cannabis-identified patients. Survival analysis showed about 96.82% of the cannabis group remained diabetes-free, compared with 99.15% of the non-user group.

Because the dataset spans multiple countries and routine clinical care settings, the results reflect real-world medical encounters rather than tightly controlled trials.

Potential biological and behavioral explanations

Investigators propose several ways cannabis might influence metabolic health.

Endocannabinoid signaling and fat distribution

One hypothesis focuses on the endocannabinoid system. Overactivation of CB1 receptors may promote fat accumulation in the abdomen and liver. That pattern contributes to insulin resistance, a central driver of type 2 diabetes.

Inflammation, oxidative stress and pancreatic effects

Other biological mechanisms under discussion include low-grade inflammation, oxidative stress, and possible dysfunction of insulin-producing β cells. These processes can disrupt glucose regulation over time.

Behavioral routes: appetite and activity

The familiar “munchies” effect may push users toward calorie-dense foods. Reduced physical activity and higher rates of tobacco or alcohol use among some cannabis users could also amplify metabolic risk.

What the study controlled for — and what it could not

The investigators used statistical matching to address known diabetes risk factors. They included age, sex, cardiovascular conditions, and co-use of other substances.

However, the study is observational and relies on diagnostic codes. That creates limits:

  • It cannot prove causation.
  • Frequency, dose, and mode of cannabis use were not precisely measured.
  • Differences in coding practices across institutions may affect case definitions.
  • Results have been presented at a scientific meeting but are not yet peer-reviewed.

Expert voices and remaining questions

Lead investigators suggest further work is needed to confirm mechanisms and to determine whether occasional use carries less risk. They emphasize that the observed link persisted even after excluding people with traditional diabetes risk factors.

Independent clinicians highlight the need to study patterns of use, product potency, and long-term metabolic outcomes. Until then, findings should be interpreted with caution.

Practical steps clinicians and users can consider now

While research continues, some lifestyle measures may reduce diabetes risk regardless of cannabis use. Healthcare experts recommend monitoring simple metabolic signals and adjusting behavior.

  • Measure waist circumference: greater than 40 inches for men or 35 inches for women signals higher insulin resistance risk.
  • Prioritize evening protein: substituting late-night snacks with about 25 grams of protein at dinner can stabilize overnight blood sugar.
  • Keep active: daily moderate-to-vigorous movement — for example, an intense 20-minute walk — improves glucose uptake by muscles.
  • Avoid frequent calorie-dense snacking after cannabis use, and be mindful of alcohol and nicotine consumption.
  • Discuss personal risk with a clinician and consider periodic screening for blood glucose if you use cannabis regularly.

Where this research fits in the bigger picture

Global cannabis use has risen in recent years. The United Nations estimated about 219 million users in 2021. Past studies have reported mixed effects of cannabis on weight and inflammation, making the new large-scale clinical-records analysis an important contribution.

Because the findings were shared at the European Association for the Study of Diabetes meeting in Vienna, they will likely prompt deeper inquiry into how cannabinoids interact with metabolic pathways. Additional longitudinal and mechanistic studies are needed to clarify cause and effect, and to test whether reducing use or changing habits can lower the apparent risk.

Similar Posts:

Rate this post
See also  Prediabetes won't stop two sisters from training for marathons

Leave a Comment

Share to...